Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5702806 | Urologic Oncology: Seminars and Original Investigations | 2016 | 8 Pages |
Abstract
In a representative cohort of patients with clinically localized PC, CTC can be detected in a considerable proportion of patients when using a new microfluidic ratchet mechanism. This encourages further studies assessing the prognostic effect of antigen-independent enriched CTC in patients with PC.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Tilman M.D., Emily Sunyong M.Sc., Simon Ph.D., Xiaoyan Ph.D., Chao M.A.Sc., Hamidreza M.D., Hongshen Ph.D., Peter C. M.D.,